By Real World Health Care Editorial Staff  |  Sep 21, 2022

American Cancer Society Funds Pioneering Research in Acute Lymphoblastic Leukemia

September is Childhood Cancer Awareness Month, an observance recognized by health care institutions, advocacy organizations, patients and families around the world. While childhood cancer is rare, it is the leading cause of disease-related death past infancy in children and adolescents, according to the National Cancer Institute. Acute Lymphoblastic Leukemia (ALL)…more.

By Real World Health Care Editorial Staff  |  Sep 7, 2022

Is a Blood or Marrow Transplant Right for You?

People with acute lymphoblastic leukemia (ALL) may have a range of treatment options available to them, including chemotherapy, targeted therapy, immunotherapy, surgery and radiation therapy. These options will vary depending on the patient’s ALL subtype, age, state of health and other prognostic factors. A patient’s cancer care team may also…more.

Categories: Leukemia
By Cancer Support Community  |  Aug 24, 2022

Managing Side Effects of Acute Lymphoblastic Leukemia Treatment

As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda’s Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through three areas: direct…more.

Categories: Leukemia
By Real World Health Care Editorial Staff  |  Jul 27, 2022

Beyond the Cure: Acute Lymphoblastic Leukemia Survivorship is a Journey

Childhood cancer survivorship is a journey. Survivors and their families need to be prepared for life after cancer, and the National Children’s Cancer Society (NCCS) is committed to them every step of the way. Real World Health Care recently interviewed NCCS’s Jessica Cook, MSW, vice president of Patient & Family…more.

Categories: Leukemia
By Real World Health Care Editorial Staff  |  Feb 9, 2022

What is Acute Lymphoblastic Leukemia and Whom Does it Affect?

Leukemia is a blood cancer that affects red blood cells, white blood cells and/or platelets. One type of leukemia, acute lymphoblastic leukemia (ALL) – also called acute lymphocytic leukemia and acute lymphoid leukemia – is a blood and bone marrow cancer that can affect both children and adults. In adults…more.

Categories: Leukemia
By Krista Zodet, President/CEO, HealthWell Foundation  |  Jan 12, 2022

Ahead in 2022: Health Equity and Chronic Diseases in the Spotlight

As I sat down to write my year-end column for 2021, I was struck by how much had changed over the course of the year…and how much remains the same. Thanks to the efforts of brilliant scientists, dedicated clinicians and determined citizens, we now have readily available vaccines (and boosters)…more.

By Real World Health Care Editorial Staff  |  Aug 4, 2021

Understanding Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a cancer that affects the blood and bone marrow and is the most common type of acute leukemia in adults. With AML, the bone marrow (the center of the bone containing many blood vessels) makes abnormal white blood cells, red blood cells or platelets. Normally,…more.

Categories: Leukemia
By Krista Zodet, President/CEO, HealthWell Foundation  |  Jan 13, 2021

Important Lessons from the COVID-19 Pandemic

As 2021 begins and we look back on the stress and devastation the COVID-19 pandemic unleashed last year, much of the future still remains uncertain. As I write this column, COVID-19 infections and deaths are at an all-time high, especially among those with pre-existing medical conditions and those in underserved…more.

Categories: General, Uncategorized
By Claire Saxton, Vice President, Education and Outreach, Cancer Support Community  |  Sep 2, 2020

CAR-T Cell Immunotherapy: What to Expect

As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda’s Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through three areas: direct…more.

By Lee Greenberger, PhD, Chief Scientific Officer, The Leukemia & Lymphoma Society  |  Aug 19, 2020

The Evolution of CAR-T Therapy

Over the past two decades there’s been tremendous progress in understanding how to harness the body’s immune system to fight cancer. Today, immunotherapy is a mainstay of cancer treatment. One of the most exciting areas of immunotherapy is CAR (chimeric antigen receptor) T-cell therapy. This treatment involves purifying a special…more.

Close menu